Cargando…
CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients
BACKGROUND: Neuroblastoma is a pediatric cancer that exhibits a wide clinical spectrum ranging from spontaneous regression in low-risk patients to fatal disease in high-risk patients. The identification of single nucleotide polymorphisms (SNPs) may help explain the heterogeneity of neuroblastoma and...
Autores principales: | Rihani, Ali, De Wilde, Bram, Zeka, Fjoralba, Laureys, Geneviève, Francotte, Nadine, Tonini, Gian Paolo, Coco, Simona, Versteeg, Rogier, Noguera, Rosa, Schulte, Johannes H., Eggert, Angelika, Stallings, Raymond L., Speleman, Frank, Vandesompele, Jo, Van Maerken, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263607/ https://www.ncbi.nlm.nih.gov/pubmed/25502557 http://dx.doi.org/10.1371/journal.pone.0114696 |
Ejemplares similares
-
Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma
por: Rihani, Ali, et al.
Publicado: (2015) -
Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
por: Kumps, Candy, et al.
Publicado: (2013) -
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
por: Gamble, Laura D., et al.
Publicado: (2021) -
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
por: Van Goethem, Alan, et al.
Publicado: (2023) -
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
por: Schramm, A, et al.
Publicado: (2012)